Highvista Strategies LLC / CYTK
Highvista Strategies LLC’s Cytokinetics Inc Position
Does Highvista Strategies LLC own Cytokinetics Inc (CYTK)? Yes — 58.6K shares worth $4M (+1.07% of its 13F portfolio) as of Q1 2026, down from 114.6K shares the prior filed quarter.
Position Value
$4M
Q1 2026
Shares
58.6K
% of Portfolio
+1.07%
Quarters Held
12
currently held
Position History CYTK
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 58.6K | $4M | +1.07% |
| Q4 2025 | 114.6K | $7M | +1.87% |
| Q3 2025 | 132.9K | $7M | +1.79% |
| Q2 2025 | 68.7K | $2M | +0.83% |
| Q1 2025 | 44.7K | $2M | +0.69% |
| Q4 2024 | 14.3K | $670,837 | +0.25% |
| Q3 2024 | 10.1K | $530,904 | +0.18% |
| Q3 2022 | 73.2K | $4M | +2.02% |
| Q2 2022 | 67.5K | $3M | +1.60% |
| Q1 2022 | 65.8K | $2M | +1.54% |
| Q4 2021 | 35.2K | $2M | +1.28% |
| Q4 2020 | 47.5K | $987,000 | +0.63% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highvista Strategies LLC’s full portfolio or all institutional holders of CYTK.